Full name
"NORDIC PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
24.41.Z - Precious metals production
24.42.Z - Aluminium production
51.46.Z
52.31.Z
74.13.Z
74.14.A
74.82.Z
74.87.B
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Total assets | 18 | 13,2 | 10,4 | -21,4 |
Total operating revenue | 0 | |||
Gross profit / loss | -4,7 | -6,3 | -5,5 | 12,3 |
Liabilities and provisions | 32,2 | 33,7 | 36,4 | 8 |
Equity | -14,2 | -20,5 | -26 | -27 |
Net profit / loss | -4,7 | -6,3 | -5,5 | 12,3 |
Current assets | 18 | 13,2 | 10,4 | -21,4 |
% | % | % | p.p. | |
Equity ratio | -78,8 | -155,3 | -251 | -95,7 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.